| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 35 | $204M | +$8.05M | -$183M | -$175M | 13F-HR | 10/16/2025, 05:02 PM | |
| Q2 2025 | 40 | $374M | +$162M | -$19M | +$143M | BLV, VGLT, EDV | 13F-HR | 7/17/2025, 02:52 PM |
| Q1 2025 | 27 | $235M | +$31.9M | -$12.1M | +$19.8M | TAXX, TXXI, TAXM, AGGS | 13F-HR | 4/22/2025, 11:13 AM |
| Q4 2024 | 25 | $210M | +$24.8M | -$21.8M | +$3.03M | TAXX, AGGS | 13F-HR | 1/21/2025, 10:54 AM |
| Q3 2024 | 22 | $208M | +$38M | -$11.7M | +$26.3M | TAXX, AGGS, WFCPRL | 13F-HR | 10/22/2024, 11:35 AM |
| Q2 2024 | 18 | $173M | +$36.4M | -$10.7M | +$25.7M | TAXX, AGGS | 13F-HR | 7/23/2024, 02:12 PM |
| Q1 2024 | 16 | $148M | +$46.8M | -$42.6M | +$4.21M | TAXX, WFCPRL | 13F-HR | 4/25/2024, 10:07 AM |
| Q4 2023 | 12 | $144M | +$23.4M | -$13M | +$10.4M | 13F-HR | 1/19/2024, 01:32 PM | |
| Q3 2023 | 10 | $128M | -$13.2M | -$13.2M | 13F-HR | 10/24/2023, 09:58 AM | ||
| Q2 2023 | 16 | $161M | -$17.9M | -$17.9M | WFCPRL, BACPRL | 13F-HR | 7/21/2023, 10:40 AM | |
| Q1 2023 | 17 | $194M | +$695K | +$695K | WFCPRL, BACPRL | 13F-HR | 4/20/2023, 10:41 AM | |
| Q4 2022 | 21 | $212M | +$1.21M | -$233K | +$973K | WFCPRL, BACPRL | 13F-HR | 1/31/2023, 10:25 AM |
| Q3 2022 | 22 | $3.39M | +$2.37K | -$10.1K | -$7.68K | WFCPRL, BACPRL | 13F-HR | 10/20/2022, 09:41 AM |
| Q2 2022 | 24 | $7.5M | +$30.6K | -$17.8M | -$17.8M | WFCPRL, BACPRL | 13F-HR | 7/21/2022, 01:00 PM |
| Q1 2022 | 21 | $29.2M | +$36.8K | -$9.12K | +$27.7K | WFCPRL, BACPRL | Restatement | 4/22/2022, 10:53 AM |
| Q4 2021 | 18 | $29.8M | +$4M | +$4M | WFCPRL, BACPRL | 13F-HR | 1/24/2022, 12:20 PM | |
| Q3 2021 | 15 | $240M | +$22.1M | -$47K | +$22.1M | 13F-HR | 10/19/2021, 01:04 PM | |
| Q2 2021 | 16 | $271M | +$51.8M | -$31.1M | +$20.8M | 13F-HR | 8/5/2021, 04:59 PM | |
| Q1 2021 | 15 | $248M | +$13.5M | -$13.2M | +$373K | 13F-HR | 4/15/2021, 11:57 AM | |
| Q4 2020 | 16 | $22.4M | +$1.9M | -$4.86K | +$1.9M | 13F-HR | 1/15/2021, 01:53 PM | |
| Q3 2020 | 19 | $5.48M | +$17.4K | -$933K | -$916K | WFCPRL, BACPRL | 13F-HR | 10/23/2020, 10:45 AM |
| Q2 2020 | 21 | $25.2M | +$2.48M | -$2.13M | +$348K | WFCPRL, BACPRL | 13F-HR | 7/22/2020, 10:37 AM |
| Q1 2020 | 13 | $8.34M | +$1.05M | -$14.9K | +$1.03M | WFCPRL, BACPRL | 13F-HR | 5/1/2020, 12:01 PM |
| Q4 2019 | 21 | $7.81M | WFCPRL, BACPRL | 13F-HR | 1/29/2020, 03:22 PM | |||
| Q3 2019 | 11 | $165K | 13F-HR | 11/12/2019, 11:15 AM | ||||
| Q2 2019 | 21 | $20.1M | +$21.5K | -$5.34K | +$16.2K | WFCPRL, BACPRL | 13F-HR | 8/12/2019, 04:36 PM |
| Q1 2019 | 24 | $8.02M | +$15.3K | -$23.3K | -$8.04K | WFCPRL, BACPRL | 13F-HR | 5/10/2019, 03:04 PM |
| Q4 2018 | 26 | $29.5M | +$136K | -$74.2K | +$62.1K | WFCPRL, BACPRL | 13F-HR | 2/12/2019, 01:45 PM |
| Q3 2018 | 24 | $7.86M | +$1.08M | +$1.08M | WFCPRL, BACPRL | 13F-HR | 11/13/2018, 05:12 AM | |
| Q2 2018 | 28 | $324M | +$9.84M | -$19.5M | -$9.71M | WFCPRL, BACPRL | Restatement | 7/25/2018, 10:51 AM |
| Q1 2018 | 29 | $349M | +$33.2M | -$16.7M | +$16.5M | WFCPRL, BACPRL | Restatement | 5/14/2018, 03:09 PM |
| Q4 2017 | 30 | $384M | +$50.9M | -$8.41M | +$42.5M | WFCPRL, BACPRL | 13F-HR | 2/13/2018, 07:37 PM |
| Q3 2017 | 31 | $358M | +$8.66M | -$8.91M | -$251K | WFCPRL, BACPRL | 13F-HR | 11/14/2017, 06:19 AM |
| Q2 2017 | 34 | $370M | +$18.4M | -$22.9M | -$4.49M | WFCPRL, BACPRL | 13F-HR | 8/11/2017, 07:39 AM |
| Q1 2017 | 33 | $385M | -$82.3M | -$82.3M | WFCPRL, BACPRL | 13F-HR | 5/11/2017, 06:38 PM | |
| Q4 2016 | 33 | $448M | +$21.8M | -$150M | -$128M | WFCPRL, BACPRL | 13F-HR | 2/13/2017, 11:42 AM |
| Q3 2016 | 34 | $604M | +$66.7M | -$9.98M | +$56.7M | WFCPRL, BACPRL | 13F-HR | 11/10/2016, 08:46 PM |
| Q2 2016 | 33 | $562M | +$62.5M | -$34.9M | +$27.6M | WFCPRL, BACPRL | 13F-HR | 8/8/2016, 08:32 PM |
| Q1 2016 | 33 | $582M | +$16.3M | -$6.72M | +$9.55M | WFCPRL, BACPRL | 13F-HR | 5/12/2016, 05:50 PM |
| Q4 2015 | 35 | $616M | +$85.9M | -$93.8M | -$7.84M | WFCPRL, BACPRL | 13F-HR | 2/12/2016, 03:02 PM |
| Q3 2015 | 34 | $616M | +$4.88M | -$7.72M | -$2.84M | WFCPRL, BACPRL | 13F-HR | 11/13/2015, 03:18 PM |
| Q2 2015 | 35 | $658M | +$83.6M | -$19.3M | +$64.4M | WFCPRL, BACPRL | 13F-HR | 8/12/2015, 03:53 PM |
| Q1 2015 | 32 | $586M | +$73.9M | -$19.4M | +$54.5M | WFCPRL, BACPRL | 13F-HR | 5/14/2015, 04:31 PM |
| Q4 2014 | 33 | $587M | +$40.9M | -$16.1M | +$24.8M | WFCPRL, BACPRL | 13F-HR | 2/17/2015, 01:01 PM |
| Q3 2014 | 33 | $643M | +$20.5M | -$65.9M | -$45.5M | WFCPRL, BACPRL | 13F-HR | 11/14/2014, 08:51 AM |
| Q2 2014 | 35 | $708M | +$35M | -$33.1M | +$1.91M | WFCPRL, BACPRL | 13F-HR | 8/14/2014, 07:57 AM |
| Q1 2014 | 35 | $704M | +$675M | +$675M | WFCPRL, BACPRL, SWU | 13F-HR | 5/15/2014, 09:00 AM | |
| Q4 2013 | 36 | $619M | WFCPRL, BACPRL, SWU | 13F-HR | 2/12/2014, 08:15 AM |